Treace Medical Concepts, Inc.
USD3.96
-0.31 (-7.22%)
CEO
John T. Treace
IPO Date
2021-04-23
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$4.29
Prev. Close
$4.27
Day Low
$3.84
Day High
$4.34
52W Low
$1.17
52W High
$7.78
Market Cap
$0.26B
Volume
0.66M
| 9,891 |
| $4.04 |
| 11 Jun 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 29,430 | $4.02 |
| 11 Jun 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 22,887 | $4.04 |
| 1 Jun 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 50,000 | $3.56 |
| 28 May 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 4,508 | $2.79 |
| 28 May 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 49,810 | $2.87 |
| 28 May 2026 | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 61,202 | $3.02 |
| 19 May 2026 | BAKEWELL JOHN K | director | A-Award | Acquired | 30,000 | $0.00 |
| 19 May 2026 | Kiernan Jane E | director | A-Award | Acquired | 30,000 | $0.00 |